Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

@article{Marmor2016RecommendationsOS,
  title={Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).},
  author={Michael F Marmor and Ulrich Kellner and Timothy Y Y Lai and Ronald B. Melles and William Francis Mieler},
  journal={Ophthalmology},
  year={2016},
  volume={123 6},
  pages={1386-94}
}
BACKGROUND The American Academy of Ophthalmology recommendations on screening for chloroquine (CQ) and hydroxychloroquine (HCQ) retinopathy are revised in light of new information about the prevalence of toxicity, risk factors, fundus distribution, and effectiveness of screening tools. PATTERN OF RETINOPATHY Although the locus of toxic damage is parafoveal in many eyes, Asian patients often show an extramacular pattern of damage. DOSE: We recommend a maximum daily HCQ use of ≤5.0 mg/kg real… CONTINUE READING